ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

SaveRxCanada.to Offers Affordable Access to Palbociclib (Ibrance) from India





Breast Cancer Patients Can Save Thousands Monthly with Trusted Generic "Palnat" at Just $4.38 Per Capsule

VANCOUVER, BC, April 14, 2025 /24-7PressRelease/ -- SaveRxCanada.to, a reliable online pharmacy serving patients across North America for over 20 years, is now making it easier and more affordable for breast cancer patients to access the life-extending medication Palbociclib (brand name: Ibrance). Through licensed suppliers in India, patients can now purchase the generic version, Palnat, for just $4.38 USD per capsule—a dramatic savings compared to U.S. pharmacy prices.

Palbociclib is a targeted therapy used in combination with hormone therapy for the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. Developed by Pfizer under the brand name Ibrance, the drug works by inhibiting cyclin-dependent kinases (CDK 4/6), which are proteins that play a role in the growth of cancer cells.

Substantial Cost Savings with Palnat from India

In the United States, a typical monthly supply of Ibrance can cost between $11,000 to $14,000 USD. By comparison, SaveRxCanada.to offers Palnat, a generic version manufactured by licensed pharmaceutical companies in India, for just $4.38 USD per capsule. For a 75 mg/day dosage (one capsule per day), the monthly cost comes to approximately $131.40 USD—representing a savings of over $10,000 USD per month.

"Our mission has always been to make essential medications affordable and accessible," said SaveRxCanada.to. "We're proud to support breast cancer patients by offering Palbociclib at a price that doesn't compromise on quality or authenticity."

What is Palbociclib (Ibrance)?

Palbociclib is used in combination with hormone therapy such as letrozole or fulvestrant for patients with:

• HR-positive, HER2-negative metastatic breast cancer
• Advanced breast cancer that has progressed following hormone therapy

It works by slowing the growth of cancer cells and prolonging the time before the disease worsens.

Common Side Effects

While Palbociclib is generally well-tolerated, some common side effects include:

• Low white blood cell counts (neutropenia)
• Fatigue
• Nausea
• Hair thinning
• Diarrhea
• Infections

More serious but less frequent side effects may include blood clots and lung inflammation. Patients should be monitored regularly by their oncologist.

How to Order Palnat from SaveRxCanada.to

As a prescription medication, Palnat requires a valid prescription from a licensed healthcare provider. SaveRxCanada.to works only with verified international suppliers that provide:

• Authentic, licensed medication
• Prescription validation
• Secure packaging and international shipping options

About SaveRxCanada.to

SaveRxCanada.to is an established online pharmacy platform that connects patients in Canada and the United States with reputable international suppliers of affordable medication. With over two decades of experience, SaveRxCanada.to is committed to making life-saving treatments accessible to those facing high drug costs.

To learn more or to order Palbociclib (Palnat), visit www.SaveRxCanada.to.



---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.